Statins Not Tied to Women's Gonado-Sexual Dysfunction

This article originally appeared here.
Share this content:
Statins Not Tied to Women's Gonado-Sexual Dysfunction
Statins Not Tied to Women's Gonado-Sexual Dysfunction

TUESDAY, Nov. 25, 2014 (HealthDay News) -- Statin use is not associated with higher risk of gonado-sexual dysfunction in women, according to a study published online Nov. 10 in the Journal of Sexual Medicine.

Sayed K. Ali, M.D., from the VA South Texas Health Care System in San Antonio, and colleagues compared the risk of gonado-sexual dysfunction in statin users and nonusers using data from female adult patients (mean age, 58 years) enrolled in the Tricare Prime/Plus San Antonio catchment area. Baseline characteristics were evaluated Oct. 1, 2003, to Sept. 30, 2005, while outcomes (menstrual disorders, menopausal disorders, infertility, and ovarian/sexual dysfunction) were evaluated over a follow-up period from Oct. 1, 2005, to March 1, 2012.

The researchers found that, based on analysis of the propensity score-matched 2,890 statin users and 2,890 nonusers, statin use was not significantly associated with menstrual disorders (odds ratio [OR], 0.97; 95 percent confidence interval [CI], 0.81 to 1.16), menopausal disorders (OR, 0.92; 95 percent CI, 0.83 to 1.02), infertility (OR, 0.79; 95 percent CI, 0.36 to 1.73), or ovarian/sexual dysfunction (OR, 1.18; 95 percent CI, 0.83 to 1.70).

"Statin use was not associated with higher risk of gonado-sexual dysfunction in women," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »